↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
wikipedia
2 Wikipedia pages
guideline
1 clinical guideline source

Readers on

mendeley
220 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements
Published in
Oncologist, August 2014
DOI 10.1634/theoncologist.2014-0241
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 220 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Netherlands 1 <1%
Japan 1 <1%
Italy 1 <1%
Unknown 217 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 29 13%
Researcher 26 12%
Student > Ph. D. Student 23 10%
Student > Bachelor 20 9%
Other 15 7%
Other 23 10%
Unknown 84 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 39 18%
Biochemistry, Genetics and Molecular Biology 26 12%
Agricultural and Biological Sciences 16 7%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Nursing and Health Professions 9 4%
Other 25 11%
Unknown 93 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2026.
All research outputs
#4,447,064
of 34,410,315 outputs
Outputs from Oncologist
#1,142
of 4,878 outputs
Outputs of similar age
#37,489
of 280,024 outputs
Outputs of similar age from Oncologist
#5
of 38 outputs
Altmetric has tracked 34,410,315 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,878 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.